A Phase III, Double-Blind, Placebo-Controlled, Randomized Study of Taselisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy
A Phase III, Double-Blind, Placebo-Controlled, Randomized Study of Taselisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy
This international, multicenter, randomized, double-blinded, placebo-controlled study is designed to compare the efficacy and safety of taselisib + fulvestrant with that of placebo + fulvestrant in postmenopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor-2 (HER2)-negative, oncogene that encodes for phosphatidylinositol-4,5-bisphosphate 3-kinase (PIK3CA)-mutant, unresectable, locally advanced or metastatic breast cancer after recurrence or progression during or after an aromatase inhibitor (AI) therapy. There will be a 2:1 randomization to the taselisib arm versus the placebo arm. Enrollment will be enriched for participants with PIK3CA mutant tumors via central testing. The anticipated duration of the study is approximately 3.5 years.
Inclusion Criteria:
Exclusion Criteria:
Marietta, Georgia 30060, United States
Rochville, Maryland 20850, United States
St Louis, Missouri 63141, United States
Harrison, New York 10604, United States
Beaverton, Oregon 97006, United States
Vancouver, British Columbia V5Z 4E6, Canada
Montreal, Quebec H3T 1E2, Canada
Naples, Campania 80131, Italy
Reggio Emilia, Emilia-Romagna 42100, Italy
Udine, Friuli Venezia Giulia 33100, Italy
Genoa, Liguria 16132, Italy
D.F., 04980, Mexico
Lima, Lima 41, Peru
Lodz, 93-513, Poland
Szczecin, 71-730, Poland
Warsaw, 02-781, Poland
Wroclaw, 51-124, Poland
Moscovskaya Oblast, Moscow Oblast 143423, Russia
Saint Petersburg, 197758, Russia
Santiago de Compostela, LA Coruña 15706, Spain
San Cristóbal de La Laguna, Tenerife 38320, Spain
Madrid, 28050, Spain
Chiang Mai, 50200, Thailand
Adana, 01230, Turkey (Türkiye)
Edirne, 22770, Turkey (Türkiye)
Sihhiye/Ankara, 06230, Turkey (Türkiye)